A-SPINE Asia Co., Ltd. (TPEX:6758)
Taiwan · Delayed Price · Currency is TWD 39.00
+0.50 (1.30%)
Apr 20, 2026, 12:45 PM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 518.64 million as of April 20, 2026. Its market cap has decreased by -9.41% in one year.
Market Cap
518.64M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
39.00
Market Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 518.64M, a decrease of -56.74%. That is a compound annual growth rate of -12.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 518.64M | -2.53% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PlexBio | 1.35B |
| Rossmax International | 1.28B |
| AViTA | 1.18B |
| Wiltrom | 1.10B |
| S&S Healthcare Holding | 964.32M |
| Radiant Innovation | 811.90M |
| AmCad BioMed | 763.16M |
| Health & Life | 545.19M |